PL2934528T3 - Quinolyl hydrazones for the treatment of tuberculosis and related diseases - Google Patents
Quinolyl hydrazones for the treatment of tuberculosis and related diseasesInfo
- Publication number
- PL2934528T3 PL2934528T3 PL13811633T PL13811633T PL2934528T3 PL 2934528 T3 PL2934528 T3 PL 2934528T3 PL 13811633 T PL13811633 T PL 13811633T PL 13811633 T PL13811633 T PL 13811633T PL 2934528 T3 PL2934528 T3 PL 2934528T3
- Authority
- PL
- Poland
- Prior art keywords
- hydrazones
- quinolyl
- tuberculosis
- treatment
- related diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT106651A PT106651A (en) | 2012-11-20 | 2012-11-20 | QUINOLIL HYDROZONES FOR THE TREATMENT OF TUBERCULOSIS AND RELATED DISEASES |
| EP13811633.0A EP2934528B1 (en) | 2012-11-20 | 2013-11-20 | Quinolyl hydrazones for the treatment of tuberculosis and related diseases |
| PCT/PT2013/000069 WO2014081325A1 (en) | 2012-11-20 | 2013-11-20 | Quinolyl hydrazones for the treatment of tuberculosis and related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2934528T3 true PL2934528T3 (en) | 2019-05-31 |
Family
ID=49876953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13811633T PL2934528T3 (en) | 2012-11-20 | 2013-11-20 | Quinolyl hydrazones for the treatment of tuberculosis and related diseases |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9809550B2 (en) |
| EP (1) | EP2934528B1 (en) |
| BR (1) | BR112015011605A2 (en) |
| CY (1) | CY1121690T1 (en) |
| DK (1) | DK2934528T3 (en) |
| ES (1) | ES2710124T3 (en) |
| HR (1) | HRP20182198T1 (en) |
| HU (1) | HUE043021T2 (en) |
| LT (1) | LT2934528T (en) |
| MA (1) | MA38207B1 (en) |
| PL (1) | PL2934528T3 (en) |
| PT (2) | PT106651A (en) |
| RS (1) | RS58185B1 (en) |
| SI (1) | SI2934528T1 (en) |
| SM (1) | SMT201900089T1 (en) |
| TR (1) | TR201900156T4 (en) |
| WO (1) | WO2014081325A1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080118576A1 (en) * | 2006-08-28 | 2008-05-22 | Dan Theodorescu | Prediction of an agent's or agents' activity across different cells and tissue types |
| EP2367820B1 (en) * | 2008-11-20 | 2016-09-21 | Panacea Biotec Limited | Novel antimicrobial agents |
| EP2287149A1 (en) * | 2009-08-20 | 2011-02-23 | Max-Delbrück-Centrum Für Molekulare Medizin | Enhancers of protein degradation |
| EP2311457A1 (en) * | 2009-10-19 | 2011-04-20 | Forschungszentrum Borstel | Pharmaceutical compositions for treating infections with drug resistant mycobacteria |
| ES2532703T3 (en) * | 2010-10-13 | 2015-03-31 | Glaxo Group Limited | 3-amino-pyrazole derivatives useful against tuberculosis |
-
2012
- 2012-11-20 PT PT106651A patent/PT106651A/en unknown
-
2013
- 2013-11-20 SI SI201331305T patent/SI2934528T1/en unknown
- 2013-11-20 BR BR112015011605A patent/BR112015011605A2/en not_active Application Discontinuation
- 2013-11-20 MA MA38207A patent/MA38207B1/en unknown
- 2013-11-20 EP EP13811633.0A patent/EP2934528B1/en active Active
- 2013-11-20 PL PL13811633T patent/PL2934528T3/en unknown
- 2013-11-20 RS RS20181598A patent/RS58185B1/en unknown
- 2013-11-20 ES ES13811633T patent/ES2710124T3/en active Active
- 2013-11-20 SM SM20190089T patent/SMT201900089T1/en unknown
- 2013-11-20 LT LTEP13811633.0T patent/LT2934528T/en unknown
- 2013-11-20 TR TR2019/00156T patent/TR201900156T4/en unknown
- 2013-11-20 PT PT13811633T patent/PT2934528T/en unknown
- 2013-11-20 WO PCT/PT2013/000069 patent/WO2014081325A1/en active Application Filing
- 2013-11-20 US US14/443,787 patent/US9809550B2/en active Active
- 2013-11-20 DK DK13811633.0T patent/DK2934528T3/en active
- 2013-11-20 HU HUE13811633A patent/HUE043021T2/en unknown
-
2018
- 2018-12-31 HR HRP20182198TT patent/HRP20182198T1/en unknown
-
2019
- 2019-01-09 CY CY20191100018T patent/CY1121690T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT106651A (en) | 2014-05-20 |
| SMT201900089T1 (en) | 2019-02-28 |
| US20150299128A1 (en) | 2015-10-22 |
| LT2934528T (en) | 2019-02-11 |
| MA38207A2 (en) | 2016-12-30 |
| US9809550B2 (en) | 2017-11-07 |
| CY1121690T1 (en) | 2020-07-31 |
| BR112015011605A2 (en) | 2017-07-11 |
| HRP20182198T1 (en) | 2019-02-22 |
| RS58185B1 (en) | 2019-03-29 |
| ES2710124T3 (en) | 2019-04-23 |
| PT2934528T (en) | 2019-03-20 |
| DK2934528T3 (en) | 2019-02-04 |
| TR201900156T4 (en) | 2019-02-21 |
| EP2934528A1 (en) | 2015-10-28 |
| EP2934528B1 (en) | 2018-11-07 |
| WO2014081325A1 (en) | 2014-05-30 |
| HUE043021T2 (en) | 2019-08-28 |
| SI2934528T1 (en) | 2019-03-29 |
| MA38207B1 (en) | 2018-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269567A (en) | Methods and processes for non-invasive assessment of genetic variations | |
| HK1223656A1 (en) | Methods and processes for non-invasive assessment of genetic variations | |
| HK1205938A1 (en) | Inhibitors of human ezh2, and methods of use thereof ezh2 | |
| HK1218173A1 (en) | Methods and processes for non-invasive assessment of genetic variations | |
| IL244748B (en) | Methods and processes for non-invasive assessment of genetic variations | |
| HK1214870A1 (en) | Methods and processes for non-invasive assessment of genetic variations | |
| EP2890440A4 (en) | Devices and methods for the treatment of vascular disease | |
| ZA201506984B (en) | Microarray for delivery of therapeutic agent and methods of use | |
| HK1211474A1 (en) | Treatment of immune-related and inflammatory diseases | |
| IL239368A0 (en) | Ppar-sparing thiazolidiones and combinations for the treatment of neurodegenerative diseases | |
| HK1207953A1 (en) | An enhanced therapeutic stimulus system and methods of use | |
| ZA201503266B (en) | Pyidone derivatives and uses thereof in the treatment of tuberculosis | |
| HRP20182198T1 (en) | Quinolyl hydrazones for the treatment of tuberculosis and related diseases | |
| HUE056531T2 (en) | Pyridyl hydrazones for the treatment of tuberculosis and related diseases |